One cold, hard fact for retail investors: Vaccines have never been big moneymakers for pharmaceutical companies, and the ones that do make it to the market have historically taken between five to seven years to develop
The market’s erratic response to lukewarm medical research for COVID-19 treatment and vaccine candidates isn’t expected to slow down as investors pin their hopes for a recovery on the high-risk biotechnology sector.
See also:Moderna's stock soars, then dips, after questions arise around the limited data shared about its COVID-19 vaccine The publication of preprints has likely been a contributor to some of the market volatility, Mellon analyst Amanda Birdsey-Benson said. “They are giving a lot of false hope and a lot of disappointment.”
Since the start of the year, the SPDR S&P Biotech Exchange-Traded Fund XBI, +0.99% has gained 7.8%, making the biotech sector a top three performer among S&P ETFs during a year in which the coronavirus pandemic has hurt markets and decimated jobs. Several virus stocks began rallying by Jan. 23. In comparison, the S&P Low Volatility Index is down 14.9% for the year, while the S&P 500 SPX, +0.48% has declined 6.2%.
“With shares now down [about] 14% from last month’s highs — that we believe were fueled by constant remdesivir newsflow and overly optimistic expectations for significant NT remdesivir revenues — we now see a greater valuation disconnect and even more attractive buying opportunity,” RBC Capital Markets’ Brian Abrahams wrote in a May 27 note to investors.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Here’s why Citi says stocks have rallied — and why new fuel for gains is now neededIt has been another incredible month for stocks, even if Thursday’s session finished on a weak note. A Citi strategist mentioned that the rally was done without flows coming into equities, which particularly for stocks outside the U.S. is rare.
Weiterlesen »
COVID-19 Is A Respiratory Disease. So Why Is It Affecting Patients’ Hearts And Brains?If there’s one symptom that’s become synonymous with COVID-19, it’s the cough. It’s not surprising, then, that many of us think of COVID-19 as strictly a respir…
Weiterlesen »
COVID-19 Is A Respiratory Disease. So Why Is It Affecting Patients’ Hearts And Brains?If there’s one symptom that’s become synonymous with COVID-19, it’s the cough. It’s not surprising, then, that many of us think of COVID-19 as strictly a respir…
Weiterlesen »
Why Rising U.S.-China Tensions Are The Biggest Threat To The Stock Market RallyTwo threats to the stock market rally are China’s growing belligerence and the slow reopening from COVID-19 lockdown in big states, such as New York, Illinois and California.
Weiterlesen »
Why Rachel Lindsay Doesn't Expect Hannah Brown to ChangeShe's going to go right back to doing what she was doing before, Rachel Lindsay said while talking about The Bachelorette's Hannah Brown
Weiterlesen »
Why Foods With Saturated Fats May Hinder Your Ability to FocusFeeling distracted? New research suggests it might be what you just ate.
Weiterlesen »